Factors influencing the production of recombinant SV40 vectors (Q45878373)

17 December 2017

title

Factors influencing the production of recombinant SV40 vectors (English)

1 reference

17 December 2017

author

Jesús Prieto

2

1 reference

17 December 2017

Puri Fortes

4

1 reference

17 December 2017

author name string

Maria Vera

1

1 reference

17 December 2017

David S Strayer

3

1 reference

17 December 2017

publication date

1 October 2004

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

780-791

1 reference

17 December 2017

A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Gene therapy using SV40-derived vectors: what does the future hold?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Simian virus 40 and human tumors: It is time to study mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Simian Virus 40 Infection of Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Major histocompatibility complex class I molecules mediate association of SV40 with caveolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Simian virus 40 infection via MHC class I molecules and caveolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Integration and excision of SV40 DNA from the chromosome of a transformed cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Random integration of SV40 in SV40-transformed, immortalized human fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Subcellular distribution of simian virus 40 T antigen species in various cell lines: the 56K protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Expression of beta-globin in primary erythroid progenitors of beta-thalassemia patients using an SV40-based gene delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Combination genetic therapy to inhibit HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Trans-activated interferon-alpha2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

HIV-1 proprotein processing as a target for gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Growth and purification of SV40 virus for biochemical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

SV40-transformed simian cells support the replication of early SV40 mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

New host cell system for regulated simian virus 40 DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Titering replication-defective virus for use in gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

Helpers for efficient encapsidation of SV40 pseudovirions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.1014

10.1016/J.YMTHE.2004.06.1014

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

15451462

1 reference

17 December 2017